Find clinical trials for Heart Disease in Dallas, TX
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Heart Disease trials near Dallas, TX, USA:
) application in patients with symptomatic heart disease due to failure of a surgical or transcatheter bioprosthetic aortic valve w...
Dallas, Texas, United States and 60 other locations
The purpose of this study is to characterize the functionality of transcatheter implantation of the Medtronic Harmony Transcatheter Pulmonary Valve (...
Dallas, Texas, United States and 19 other locations
To demonstrate the safety and effectiveness of the Edwards Alterra Adaptive Prestent in conjunction with the Edwards SAPIEN 3 Transcatheter Heart...
Dallas, Texas, United States of America and 13 other locations
PumpKIN is a multicenter, prospective, single-arm feasibility study; Evaluating the investigational Jarvik 2015 VAD in pediatric patients with heart...
Early Phase 1
Dallas, Texas, United States and 6 other locations
To assess the safety and effectiveness of the SAPIEN 3 transcatheter heart valve in patients with a failing mitral bioprosthetic valve....
Plano, Texas, United States and 11 other locations
This study will evaluate the clinical efficacy and safety of udenafil, an orally administered, potent and selective inhibitor of PDE5, versus placebo...
Phase 3
Dallas, Texas, United States and 39 other locations
Multi-center, prospective, randomized controlled study comparing PCI guided by angiography versus iFR Co-Registration using commercially available Ph...
Plano, Texas, United States and 83 other locations
To collect information about treatment for symptomatic severe Aortic Regurgitation (AR), which affects the aortic valve in the heart. Aortic...
Dallas, Texas, United States and 29 other locations
of the Cordella™ Pulmonary Artery Sensor System in NYHA Class II-III Heart Failure Patients (PROACTIVE-HF-2 Trial).The study contains of 5 a...
Dallas, Texas, United States and 47 other locations
with placebo in reducing the risk of the clinical consequences of AKI (MAKE) at 90 days in adult participants with CKD who undergo non-emergent cardiac...
Phase 3
Dallas, Texas, United States and 213 other locations
Clinical trials
Research sites
Resources
Legal